Guanfacine in Comorbid ADHD & Tourette’s Syndrome

J Gordon Millichap

doi:10.15844/pedneurbriefs-9-9-3

Guanfacine in Comorbid ADHD & Tourette’s Syndrome

Pediatric Neurology Briefs

Volume 9 (1995): Issue 9

By: J Gordon Millichap

Open Access

|Sep 1995

Abstract

An open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.

References

Chappell PB Riddle MA Scahill L Lynch KA Schultz R Arnsten A Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience J Am Acad Child Adolesc Psychiatry 1995 Sep 34 9 1140 6 7559307 10.1097/00004583-199509000-00010
Open DOI Search in Google Scholar Back to article
Lombroso PJ Scahill L King RA Lynch KA Chappell PB Peterson BS Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report J Am Acad Child Adolesc Psychiatry 1995 Sep 34 9 1147 52 7559308 10.1097/00004583-199509000-00011
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-9-9-3 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 66 - 67

Published on: Sep 1, 1995

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Open-Label Study,

Commission Errors,

Phonic Tics

© 1995 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 9 (1995): Issue 9